Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5619 | 1532 | 32.1 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1007 | 9877 | CREATINE//MAGNETIC RESONANCE SPECTROSCOPY//ARGININE KINASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P 31 MRS | Author keyword | 8 | 21% | 2% | 33 |
2 | PHOSPHORUS MR SPECTROSCOPY | Author keyword | 5 | 63% | 0% | 5 |
3 | P 31 MRSI | Author keyword | 3 | 60% | 0% | 3 |
4 | P 31 MR SPECTROSCOPY | Author keyword | 3 | 25% | 1% | 9 |
5 | P 31 MAGNETIC RESONANCE SPECTROSCOPY | Author keyword | 3 | 12% | 1% | 19 |
6 | HETERONUCLEAR SINGLE QUANTUM CORRELATION | Author keyword | 2 | 67% | 0% | 2 |
7 | IN VIVO P 31 MAGNETIC RESONANCE SPECTROSCOPY | Author keyword | 2 | 67% | 0% | 2 |
8 | P 31 MR SPECTROSCOPIC IMAGING | Author keyword | 2 | 67% | 0% | 2 |
9 | PHOSPHOENERGETICS | Author keyword | 2 | 67% | 0% | 2 |
10 | WORLD WIDE CLIN TECHNOL | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SIZE DEPENDENT CHANGES | 21 | 90% | 1% | 9 |
2 | LEUKEMIA CELL TUMORS | 18 | 89% | 1% | 8 |
3 | P 31 MR SPECTROSCOPY | 16 | 31% | 3% | 44 |
4 | P 31 NMR SPECTROSCOPY | 6 | 11% | 4% | 58 |
5 | BREAST CANCER SPHEROIDS | 6 | 80% | 0% | 4 |
6 | TUMOR ENERGY METABOLISM | 6 | 100% | 0% | 4 |
7 | PHOSPHOMONOESTER | 5 | 54% | 0% | 7 |
8 | PHOSPHOLIPID METABOLITES | 5 | 45% | 1% | 9 |
9 | RENAL VIABILITY | 5 | 63% | 0% | 5 |
10 | RIF 1 TUMORS | 4 | 23% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Tumour phospholipid metabolism | 1999 | 339 | 189 | 44% |
IN-VIVO P-31 MRS OF EXPERIMENTAL-TUMORS | 1993 | 104 | 155 | 70% |
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized P-31 measurements of response to treatment | 1998 | 79 | 85 | 55% |
In vivo magnetic resonance spectroscopy in cancer | 2005 | 108 | 223 | 30% |
MAGNETIC-RESONANCE SPECTROSCOPY OF TUMORS AND POTENTIAL INVIVO CLINICAL-APPLICATIONS - A REVIEW | 1989 | 176 | 84 | 56% |
Methodological standardization for a multi-institutional in vivo trial of localized P-31 MR spectroscopy in human cancer research. In vitro and normal volunteer studies | 2004 | 17 | 12 | 83% |
Metabolic changes underlying P-31 MR spectral alterations in human hepatic tumours | 1998 | 32 | 31 | 65% |
RESPONSE OF SOLID TUMORS TO CHEMOTHERAPY MONITORED BY INVIVO P-31 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY | 1989 | 125 | 70 | 70% |
Hepatic P-31 magnetic resonance spectroscopy: a hepatologist's user guide | 2005 | 20 | 34 | 71% |
Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: A review | 2008 | 40 | 48 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WORLD WIDE CLIN TECHNOL | 2 | 67% | 0.1% | 2 |
2 | CLIN ONCOL RADIOTHER EUT UNIT | 1 | 38% | 0.2% | 3 |
3 | BR AMBEDKER BIOMED | 1 | 100% | 0.1% | 2 |
4 | UMR 5536 CNRS | 1 | 40% | 0.1% | 2 |
5 | CRC CLIN MAGNET ONANCE GRP | 1 | 33% | 0.1% | 2 |
6 | AFDELING RONTGENDIAG | 1 | 50% | 0.1% | 1 |
7 | BIOCHIM BIOPHYS SYST INTEG IRTSV BBSI | 1 | 50% | 0.1% | 1 |
8 | EPR DIAGNOST RADIOL | 1 | 50% | 0.1% | 1 |
9 | EX TRAIL IBIOUNITE MIXTE RECH 5536 | 1 | 50% | 0.1% | 1 |
10 | LUNDBERG WALLENBERG | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000210792 | P 31 MRS IN VITRO//SUGAR CATARACT//PHOSPHATIC METABOLITES |
2 | 0.0000183420 | CARDIAC SPECTROSCOPY//CARDIAC MAGNETIC RESONANCE SPECTROSCOPY//HIGH ENERGY PHOSPHATE |
3 | 0.0000178970 | P 31 MRS//P 31 MAGNETIC RESONANCE SPECTROSCOPY//PCR RECOVERY |
4 | 0.0000177556 | FAST PADE TRANSFORM//CHOLINE KINASE//CHOLINE KINASE INHIBITORS |
5 | 0.0000174615 | MICROCYSTIS FIRMA//CINNABARIN//AFRC ARABLE CROPS LONG ASHTON STN |
6 | 0.0000136755 | MAGNETIC RESONANCE SPECTROSCOPY//SPECTROSCOPIC IMAGING//LCMODEL |
7 | 0.0000121229 | IN VIVO O 17 NMR//O 17 MRS//CEREBRAL METABOLIC RATE OF OXYGEN UTILIZATION |
8 | 0.0000102039 | PHLIP//TUMOR ACIDITY//TUMOR PH |
9 | 0.0000099348 | GRAPE ALGORITHM//ROTATING FRAME IMAGING//BEBOP |
10 | 0.0000094763 | HIGH SPECTRAL AND SPATIAL RESOLUTION IMAGING//ECHO PLANAR SPECTROSCOPIC IMAGING EPSI//ECHO PLANAR SPECTROSCOPIC IMAGING |